Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
      QxMD      Google Scholar   
Citation:
Neuro-oncology vol 20 (4) 546-56
Year:
2018
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
SDC:
No
Book Volume:
7
Parents:
956   2121   2471  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10CA003927, U10CA032291, U10CA047559, U10CA138561, U10CA180790, U10CA180838, U10CA180867, P30CA016086, Damon Runyon Cancer Research Foundation (CI-45-09) grant  
Corr. Author:
 
Authors:
                                           
Networks:
ADM403, ALLIANCE, ATLANTIC, CA136, KANSAS, KS055, KS056, KS064, LAPS-MA036, LAPS-MN026, NC002, VA009, VCU   
Study
N0874
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1/2
Keywords: